TSE:APHA Aphria (APHA) Stock Price, News & Analysis → What’s Really Next for America… (From Porter & Company) (Ad) Free APHA Stock Alerts C$16.55 -0.98 (-5.59%) (As of 05/4/2021) Add Compare Share Share Today's RangeC$16.41▼C$17.5250-Day RangeC$16.55▼C$16.5552-Week RangeC$3.93▼C$40.93Volume9.61 million shsAverage Volume6.16 million shsMarket CapitalizationC$5.24 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Aphria alerts: Email Address Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action About Aphria Stock (TSE:APHA)Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Read More APHA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APHA Stock News HeadlinesMay 8, 2024 | americanbankingnews.comAphria (TSE:APHA) Shares Down 5.6% October 7, 2022 | finance.yahoo.comGlobal Legal Cannabis Market Report 2022-2030 Featuring Gw Pharmaceuticals, Aurora, Aphria, Cronos, Tilray, Sundial Growers, Insys Therapeutics, Scotts Co, Vivo Cannabis, & Cara Therapeutics - Yahoo FinanceOctober 4, 2022 | marketscreener.comTilray Medical Relaunches Cannabis Oral Solution Across Ireland - Marketscreener.comOctober 1, 2022 | benzinga.comGlobal Cannabis Extract Market to Reach $15.5 Billion by 2030 at a CAGR of 20.6% - BenzingaSeptember 30, 2022 | globenewswire.comGlobal Medical Marijuana Market Report 2022-2030: Surge in the Number of Countries Legalizing the Usage of Medical Marijuana - GlobeNewswireSeptember 26, 2022 | globenewswire.comGlobal Legal Cannabis Market Analysis Report 2022: A $134.4 Billion Industry by 2030, Growing at a CAGR of Over 25% - GlobeNewswireSeptember 21, 2022 | globenewswire.comGlobal Cannabis Extract Market Report 2022: Elimination of the Black Market Through the Legalization of Medical Cannabis Drives Growth - GlobeNewswireSeptember 8, 2022 | investing.comTilray Simply Needs To Do Better | investing.com - Investing.comSeptember 6, 2022 | financialpost.comTilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany - Financial PostSeptember 1, 2022 | seekingalpha.comTilray Brands: No One Is Happy (NASDAQ:TLRY) - Seeking AlphaAugust 30, 2022 | theglobeandmail.comCannabis producer Tilray lays off at least 22 migrant farm workers - The Globe and MailAugust 25, 2022 | gurufocus.comTilray Medical Launches New Products and 'CannaPoints' Program to Support Patients Across Canada - GuruFocus.comAugust 25, 2022 | globenewswire.comTilray Medical Launches New Products and 'CannaPoints' - GlobeNewswireAugust 16, 2022 | businesswire.comNorth America Legal Marijuana Market Size, Share & Trends Analysis Report 2022-2030 - ResearchAndMarkets.com - Business WireAugust 2, 2022 | benzinga.comCanopy Growth Taps Ex Aphria Executive Christelle Gedeon As New Chief Legal Officer - BenzingaJuly 25, 2022 | fool.ca3 Stocks That Have Flopped Hard This Year - The Motley Fool CanadaJune 25, 2022 | nasdaq.com5 Growth Stocks to Buy for 5-Bagger Returns in 5 Years - NasdaqJune 22, 2022 | streetinsider.comTilray Medical Welcomes Government of Luxembourg Delegation Visit to European Campus in Portugal - StreetInsider.comJune 13, 2022 | forbes.comA Sneak Preview Of Diplo And Rob Dyrdek’s New Cannabis Seltzers, Leisuretown - ForbesMay 25, 2022 | law360.comBrewer Accused Of Infringing Label Art Rights In $31M Case - Law360May 17, 2022 | seekingalpha.comTilray Brands: Almost Good Enough - Seeking AlphaMay 12, 2022 | fool.comDown 80% From Its High, Can Tilray Stock Spark Again? - The Motley FoolMay 10, 2022 | law360.comJudge Vacates Pot Co. Investors' Class Certification, For Now - Law360April 14, 2022 | thestreet.comTilray Stock: Experts Forecast More Than 20% Upside Potential - TheStreetApril 6, 2022 | marketscreener.comTILRAY BRANDS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.comSee More Headlines Receive APHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:APHA CUSIPN/A CIKN/A Webwww.aphria.com Phone844-427-4742FaxN/AEmployees1,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio59.29 Current Ratio3.37 Quick Ratio1.63 Sales & Book Value Annual SalesC$611.06 million Price / Sales8.58 Cash FlowC$0.74 per share Price / Cash Flow22.40 Book ValueC$4.76 per share Price / Book3.48Miscellaneous Outstanding Shares316,795,000Free FloatN/AMarket CapC$5.24 billion OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Irwin D. Simon (Age 62)CEO & Chairman Comp: $6.54MMr. Carl A. MertonChief Financial OfficerDr. Christelle Gedeon L.L.B.Ph.D., Chief Legal Officer & Corp. Sec.Mr. James R. MeiersChief Operating Officer of Aphria LeamingtonMs. Denise Menikheim Faltischek (Age 48)Chief Strategy Officer & MD of Aphria Germany Comp: $562.35kMr. John B. SadlerVP of Investor RelationsMr. Bernard YeungSr. VP of Sales & MarketingMr. Victor Neufeld (Age 67)Special Advisor Mr. Cole Cacciavillani (Age 66)Special Advisor Mr. Randy DaigneauSr. VP of Supply ChainMore ExecutivesKey CompetitorsBausch Health CompaniesTSE:BHCTilray BrandsTSE:TLRYCronos GroupTSE:CRONValeant Pharmaceuticals InternationalTSE:VRXBELLUS HealthTSE:BLUView All Competitors APHA Stock Analysis - Frequently Asked Questions How have APHA shares performed in 2024? Aphria's stock was trading at C$16.55 at the start of the year. Since then, APHA stock has increased by 0.0% and is now trading at C$16.55. View the best growth stocks for 2024 here. What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Organigram (OGI), KushCo (KSHB), NVIDIA (NVDA), CannTrust (CTST), Cronos Group (CRON) and Cronos Group (CRON). How do I buy shares of Aphria? Shares of APHA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:APHA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aphria Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
